Kempharm Inc buy Quitte
Start price
15.06.16
/
50%
€4.26
Target price
15.12.16
€4.73
Performance (%)
-27.97%
End price
15.12.16
€3.07
Summary
This prediction ended on 15.12.16 with a price of €3.07. The price of Kempharm Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.97%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Kempharm Inc | - | - | - | - |
iShares Core DAX® | 2.687% | -4.620% | 11.789% | 9.959% |
iShares Nasdaq 100 | 5.569% | -7.315% | 24.297% | 36.179% |
iShares Nikkei 225® | 3.756% | -7.813% | 10.017% | 3.466% |
iShares S&P 500 | 3.959% | -3.697% | 21.637% | 35.681% |
Comments by Quitte for this prediction
In the thread Kempharm Inc diskutieren
nach dem Absturz ist vor dem Anstieg
Shares of KemPharm Inc. (KMPH) were down over 26% in extended trading on Monday, following the receipt of FDA's complete response letter for the company's New drug Application for Apadaz.
(Laufzeit überschritten)